NOVELION THERAPEUTICS INC. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014
Net revenues
Cost of product sales
Operating expenses:
Selling, general and administrative
Depreciation
Research and development
Restructuring charges
Termination fee
Total operating expenses
Loss from operations
Net foreign exchange gains (losses)
Fair value change in contingent consideration (Notes 7, 14)
Other gains
Interest expense, net
Fair value loss on investment
Other expense, net
Total other (expense) income
Loss before provision for income taxes
Provision for income taxes
Net loss and comprehensive loss
Loss from continuing operations
Loss from discontinued operations, net of income taxes
Net loss
Discontinued operations
Discontinued operation (in dollars per share)
Net loss per common share—basic and diluted (in dollars per share)
Weighted-average common shares outstanding—basic and diluted (in shares)

Comments